Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Louisiana ‘Netflix’ Model For Hepatitis C Drugs Caps Spending At $35m Per Year

13 Jan 2019

• By Cathy Kelly

Spanish moss in the Louisiana Bayou - Image — Bayou State Takes The Lead In New Purchasing Approach

Related Content

Gilead’s HCV Authorized Generics Effort Will Draw Market Share From AbbVie

24 Sep 2018

Gilead Lowering HCV Drug List Prices With Authorized Generics

25 Sep 2018

Louisiana Purchase: State Eager To Test “Netflix Model” For Rx Spending

04 Oct 2018

Related Companies

Gilead Sciences, Inc.

AbbVie Inc.

Additional Topics

United States Pricing Strategies Medicaid Policy BioPharmaceutical

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.